EVIIVE

EVIIVE

Biotechnologieforschung

Unleash the full potential of liquid biopsies for the earliest disease prevention and personalized treatment guidance

Info

Revolutionizing healthcare through advanced liquid biopsies: Uncovering novel biomarkers for early diagnosis, precise prognosis, and continuous monitoring of host responses

Branche
Biotechnologieforschung
Größe
2–10 Beschäftigte
Hauptsitz
Zürich
Art
Privatunternehmen
Gegründet
2022
Spezialgebiete
Cancer, Infectious Disease, Aging, Precision medicine, Liquid biopsies, Machine learning, Biomarkers, Diagnosis, Prognosis, extracellular vesicles und exosome

Orte

Beschäftigte von EVIIVE

Updates

Ähnliche Seiten